Perek N, Prevot N, Koumanov F, Frere D, Sabido O, Beauchesne P, Dubois F
Department of Biophysics and Image Treatment, Research Group "Cell Death and Neoplasia," Faculty of Medicine Jacques Lisfranc, Saint Etienne, France.
Nucl Med Biol. 2000 Apr;27(3):299-307. doi: 10.1016/s0969-8051(00)00085-8.
The objective of this study was to compare the accumulation of Tc-99m-tetrofosmin and Tc-99m-sestamibi in four grade IV glioma cell lines and to correlate their accumulation with the multidrug resistance of the cells. Tc-99m-tetrofosmin in all glioma cell lines showed slightly higher uptake and more efficient release beyond 150 min than Tc-99m-sestamibi and the retention of both tracers in the cells was to a certain extend inversely proportional to their degree of multidrug resistance. The results obtained showed that the efflux of both tracers was carried out only in part through the MRP/GS-X pump system. Tc-99m-tetrofosmin showed good potential as a marker of recurrent malignant glioma and in vivo studies are currently underway to confirm these observations.